Results 81 to 90 of about 8,058,247 (342)

Nurses’ Intentions, Awareness and Barriers in Reporting Adverse Events: A Cross-Sectional Survey in Tertiary Hospitals in China

Risk Management and Healthcare Policy, 2022
Xiaoying Zhao,1 Chunhong Shi,2,3 Lihua Zhao1 1Handan First Hospital, Handan, 056000, People’s Republic of China; 2School of Nursing, Xiangnan University, Chenzhou, People’s Republic of China; 3Affiliated Hospital of Xiangnan University, Chenzhou, 423000,
Zhao X, Shi C, Zhao L
doaj  

Tracking Progress towards the International Safeguards for Children in Sport

Social Sciences, 2022
In 2018, a review was conducted to explore sporting organisations’ use of global safeguarding policies. Due to an increase in the number of organisations now adopting these policies, it is thought that an up-to-date review should be conducted to ...
Amy Lorraine Wilson, Daniel J. A. Rhind
doaj   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Leadership Style and Safety Culture in Commuter Railroads

Safety
Previous research has repeatedly demonstrated the importance of both safety culture and leadership in promoting workplace safety. Several studies and reviews have identified transformational leadership style as an important contributor to a strong safety
Patrick Sherry
doaj   +1 more source

Safety Culture ≈ Multi - Dimensional Phenomenon [PDF]

, 2017
Článok poukazuje na rozdielnosť vnímania pojmu kultúra bezpečnosti v odbornej sfére ako aj na nejednotu defi nícií pojmu. Prezentuje možné modely fungovania kultúry bezpečnosti a základné otázky, ktoré je nutné zodpovedať.
Osadská, Ivana, Osadská, Vladimíra, Slováčková, Ivana   +2 more
core  

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

The Effectiveness of Multidisciplinary Team Huddles in Healthcare Hospital-Based Setting

Journal of Multidisciplinary Healthcare, 2022
Shih Ping Lin,1– 3 Ching-Wein Chang,4 Chun-Yi Wu,1,5 Chun-Shih Chin,1,6 Cheng-Hsien Lin,1,7 Sz-Iuan Shiu,1,8 Yun-Wen Chen,1,9 Tsai-Hung Yen,1,9 Hui-Chi Chen,4 Yi-Hung Lai,4 Shu-Chin Hou,4 Ming-Ju Wu,3,5 Hsin-Hua Chen1,3,9– 11 1Division of ...
Lin SP, Chang CW, Wu CY, Chin CS, Lin CH, Shiu SI, Chen YW, Yen TH, Chen HC, Lai YH, Hou SC, Wu MJ, Chen HH   +12 more
doaj  

The safety culture of the Ljubljana community health centre’s employees

Slovenian Journal of Public Health, 2021
Patient safety is one of the key aspects of healthcare quality and a serious global public health concern. Patient safety culture is a part of the patient safety concept.
Tevžič Špela, Poplas-Susič Antonija, Klemenc-Ketiš Zalika   +2 more
doaj   +1 more source

Patient safety in Europe: medication errors and hospital-acquired infections [PDF]

, 2008
The Report was commissioned by the European Federation of Nurses Associations (EFN) in November 2007 in order to support its policy statements on Patient Safety (June 2004).
Burke, J., Smith, L.N., Sveinsdóttir, H., Willman, A.   +3 more
core   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source